Thursday, March 31, 2022 2:43:03 PM
Recent SABS News
- SAB Biotherapeutics Provides SAB-142 Trial Update • GlobeNewswire Inc. • 04/16/2024 11:15:00 AM
- SAB Biotherapeutics to Present at INNODIA Annual Meeting • GlobeNewswire Inc. • 04/08/2024 11:15:00 AM
- SAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/04/2024 11:15:00 AM
- SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results • GlobeNewswire Inc. • 03/29/2024 11:15:00 AM
- SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment • GlobeNewswire Inc. • 03/25/2024 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:30:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:55:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:45:19 PM
- SAB Biotherapeutics to Present at the BIO CEO & Investor Conference • GlobeNewswire Inc. • 02/23/2024 01:00:00 PM
- SAB Biotherapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/08/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 12:53:44 PM
- SAB Biotherapeutics Announces Executive Leadership Change • GlobeNewswire Inc. • 02/02/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 09:15:19 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/26/2024 09:00:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 10:00:09 PM
- SAB Biotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 01/23/2024 10:58:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:21:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 02:00:08 PM
- SAB Biotherapeutics Announces 1-for-10 Reverse Stock Split • GlobeNewswire Inc. • 01/02/2024 09:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/18/2023 02:34:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/08/2023 10:26:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/30/2023 10:00:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 12:40:46 PM
- SAB Biotherapeutics Announces Commencement of the HUMAN Phase 1 Clinical Trial with SAB-142, a Potential Disease-Modifying Treatment for Type 1 Diabetes • GlobeNewswire Inc. • 11/29/2023 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/29/2023 05:15:09 AM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM